Photobiomodulation, Transmucosal Laser Irradiation of Blood, or B complex as alternatives to treat Covid-19 Related Long-Term Taste Impairment : double-blind randomized clinical trial
© 2023. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature..
COVID-19 Related Long-Term Taste Impairment (CRLTTI) is a condition that can be expressed after COVID-19 contagion, lasting for months or even years, affecting the routine and quality of life of individuals. Participants expressing CRLTTI, with a minimum of 2 months, attested by PCR-RT test were assessed for taste and smell, and underwent experimental treatments in 6 distinct groups: Photobiomodulation (PBM) in tongue dorsum and lateral (660 nm, 808 nm, association of 660 and 808 nm), Transmucosal Laser Irradiation of Blood (TLIB)-ventral surface of tongue (660 nm), B complex supplementation, and Sham laser. No intergroup statistical differences were observed at the final evaluation, despite the tendencies of better results with PBM and TLIB observed. PBM, TLIB, and B complex might be treatment options in the management of CRLTTI, despite the lack of total remission of taste and smell perception after 8 sessions (PBM and TLIB) or 30 days of B complex supplementation.
| Errataetall: |
ErratumIn: Lasers Med Sci. 2023 Nov 20;38(1):270. - PMID 37982876 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Lasers in medical science - 38(2023), 1 vom: 10. Nov., Seite 261 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cardoso Soares, Pedro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
B Complex |
|---|
| Anmerkungen: |
Date Completed 17.11.2023 Date Revised 22.12.2023 published: Electronic ErratumIn: Lasers Med Sci. 2023 Nov 20;38(1):270. - PMID 37982876 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10103-023-03917-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364395869 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364395869 | ||
| 003 | DE-627 | ||
| 005 | 20231227135933.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10103-023-03917-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1235.xml |
| 035 | |a (DE-627)NLM364395869 | ||
| 035 | |a (NLM)37947919 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cardoso Soares, Pedro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Photobiomodulation, Transmucosal Laser Irradiation of Blood, or B complex as alternatives to treat Covid-19 Related Long-Term Taste Impairment |b double-blind randomized clinical trial |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.11.2023 | ||
| 500 | |a Date Revised 22.12.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumIn: Lasers Med Sci. 2023 Nov 20;38(1):270. - PMID 37982876 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature. | ||
| 520 | |a COVID-19 Related Long-Term Taste Impairment (CRLTTI) is a condition that can be expressed after COVID-19 contagion, lasting for months or even years, affecting the routine and quality of life of individuals. Participants expressing CRLTTI, with a minimum of 2 months, attested by PCR-RT test were assessed for taste and smell, and underwent experimental treatments in 6 distinct groups: Photobiomodulation (PBM) in tongue dorsum and lateral (660 nm, 808 nm, association of 660 and 808 nm), Transmucosal Laser Irradiation of Blood (TLIB)-ventral surface of tongue (660 nm), B complex supplementation, and Sham laser. No intergroup statistical differences were observed at the final evaluation, despite the tendencies of better results with PBM and TLIB observed. PBM, TLIB, and B complex might be treatment options in the management of CRLTTI, despite the lack of total remission of taste and smell perception after 8 sessions (PBM and TLIB) or 30 days of B complex supplementation | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a B Complex | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Photobiomodulation | |
| 650 | 4 | |a Smell disorders | |
| 650 | 4 | |a Taste disorders | |
| 700 | 1 | |a de Freitas, Patrícia Moreira |e verfasserin |4 aut | |
| 700 | 1 | |a Eduardo, Carlos de Paula |e verfasserin |4 aut | |
| 700 | 1 | |a Azevedo, Luciane Hiramatsu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lasers in medical science |d 1996 |g 38(2023), 1 vom: 10. Nov., Seite 261 |w (DE-627)NLM085855936 |x 1435-604X |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2023 |g number:1 |g day:10 |g month:11 |g pages:261 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10103-023-03917-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2023 |e 1 |b 10 |c 11 |h 261 | ||